Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
MedTech
Chai tees up BMS AI antibody discovery collab
A month after Chai Discovery tied up a major $400 million series C funding round, the AI drug discovery firm has teamed up with Bristol Myers Squibb.
Ben Adams
Aug 20, 2026 10:55am
Fierce Pharma
Editor’s Corner: Why an AZ-BMS merger would be a very bad idea
Aug 3, 2026 12:25am
BMS CEO doesn’t ‘feel any compulsion to chase deals’
Jul 30, 2026 10:37am
Fierce Pharma
BMS delays key Cobenfy, milvexian readouts amid Q2 beat
Jul 30, 2026 10:12am
InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test
Jul 27, 2026 10:08am
BMS, Nvidia aim for ‘most powerful AI factory in life sciences’
Jul 20, 2026 10:30am
Fierce Pharma
Fierce Pharma
Fierce Pharma
Fierce Pharma
